Clinical Trial Update: Albiglutide Thorough ECG Study in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 ECG-focused study of albiglutide conducted in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Albiglutide (albiglutide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED